182 related articles for article (PubMed ID: 37794586)
21. Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancer.
Wang C; Aikemu B; Shao Y; Zhang S; Yang G; Hong H; Huang L; Jia H; Yang X; Zheng M; Sun J; Li J
BMC Cancer; 2022 Jul; 22(1):818. PubMed ID: 35883111
[TBL] [Abstract][Full Text] [Related]
22. Evidence of a preferred molecular pathway in patients with synchronous colorectal cancer.
Dykes SL; Qui H; Rothenberger DA; García-Aguilar J
Cancer; 2003 Jul; 98(1):48-54. PubMed ID: 12833454
[TBL] [Abstract][Full Text] [Related]
23. Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer.
Zaravinos A; Roufas C; Nagara M; de Lucas Moreno B; Oblovatskaya M; Efstathiades C; Dimopoulos C; Ayiomamitis GD
J Exp Clin Cancer Res; 2019 Aug; 38(1):364. PubMed ID: 31429779
[TBL] [Abstract][Full Text] [Related]
24. Molecular Profiling Provides Clinical Insights Into Targeted and Immunotherapies as Well as Colorectal Cancer Prognosis.
Guo L; Wang Y; Yang W; Wang C; Guo T; Yang J; Shao Z; Cai G; Cai S; Zhang L; Hu X; Xu Y
Gastroenterology; 2023 Aug; 165(2):414-428.e7. PubMed ID: 37146911
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer.
Zang YS; Dai C; Xu X; Cai X; Wang G; Wei J; Wu A; Sun W; Jiao S; Xu Q
Cancer Med; 2019 Aug; 8(10):4699-4708. PubMed ID: 31270941
[TBL] [Abstract][Full Text] [Related]
26. Whole Exome Sequencing of Ulcerative Colitis-associated Colorectal Cancer Based on Novel Somatic Mutations Identified in Chinese Patients.
Yan P; Wang Y; Meng X; Yang H; Liu Z; Qian J; Zhou W; Li J
Inflamm Bowel Dis; 2019 Jul; 25(8):1293-1301. PubMed ID: 30794281
[TBL] [Abstract][Full Text] [Related]
27. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
[TBL] [Abstract][Full Text] [Related]
28. Exome and immune cell score analyses reveal great variation within synchronous primary colorectal cancers.
Hänninen UA; Wirta EV; Katainen R; Tanskanen T; Hamberg J; Taipale M; Böhm J; Renkonen-Sinisalo L; Lepistö A; Forsström LM; Pitkänen E; Palin K; Seppälä TT; Mäkinen N; Mecklin JP; Aaltonen LA
Br J Cancer; 2019 Apr; 120(9):922-930. PubMed ID: 30894686
[TBL] [Abstract][Full Text] [Related]
29. Molecular profile and copy number analysis of sporadic colorectal cancer in Taiwan.
Lin CH; Lin JK; Chang SC; Chang YH; Chang HM; Liu JH; Li LH; Chen YT; Tsai SF; Chen WS
J Biomed Sci; 2011 Jun; 18(1):36. PubMed ID: 21645411
[TBL] [Abstract][Full Text] [Related]
30. Genomic Alterations of NTRK, POLE, ERBB2, and Microsatellite Instability Status in Chinese Patients with Colorectal Cancer.
Guo Y; Guo XL; Wang S; Chen X; Shi J; Wang J; Wang K; Klempner SJ; Wang W; Xiao M
Oncologist; 2020 Nov; 25(11):e1671-e1680. PubMed ID: 32627883
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic features of synchronous colorectal carcinoma: A distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis.
Hu H; Chang DT; Nikiforova MN; Kuan SF; Pai RK
Am J Surg Pathol; 2013 Nov; 37(11):1660-70. PubMed ID: 23887157
[TBL] [Abstract][Full Text] [Related]
32. Intratumoral Heterogeneity of Frameshift Mutations in MECOM Gene is Frequent in Colorectal Cancers with High Microsatellite Instability.
Choi EJ; Kim MS; Song SY; Yoo NJ; Lee SH
Pathol Oncol Res; 2017 Jan; 23(1):145-149. PubMed ID: 27620344
[TBL] [Abstract][Full Text] [Related]
33. Intratumoral Heterogeneity of Frameshift Mutations of GLI1 Encoding a Hedgehog Signaling Protein in Colorectal Cancers.
Lee JH; Song SY; Kim MS; Yoo NJ; Lee SH
Pathol Oncol Res; 2018 Jul; 24(3):477-481. PubMed ID: 28664474
[TBL] [Abstract][Full Text] [Related]
34. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
[TBL] [Abstract][Full Text] [Related]
35. Molecular heterogeneity and prognostic implications of synchronous advanced colorectal neoplasia.
Malesci A; Basso G; Bianchi P; Fini L; Grizzi F; Celesti G; Di Caro G; Delconte G; Dattola F; Repici A; Roncalli M; Montorsi M; Laghi L
Br J Cancer; 2014 Mar; 110(5):1228-35. PubMed ID: 24434431
[TBL] [Abstract][Full Text] [Related]
36. Genomic amplification of chromosome 20q13.33 is the early biomarker for the development of sporadic colorectal carcinoma.
Bui VM; Mettling C; Jou J; Sun HS
BMC Med Genomics; 2020 Oct; 13(Suppl 10):149. PubMed ID: 33087131
[TBL] [Abstract][Full Text] [Related]
37. [Correlation between microsatellite instability and morphology in colorectal cancer].
Szentirmay Z; Gallai M; Serester O; Szoke J; Tóth E
Magy Onkol; 2010 Jun; 54(2):169-78. PubMed ID: 20576594
[TBL] [Abstract][Full Text] [Related]
38. The Evolving Role of Consensus Molecular Subtypes: a Step Beyond Inpatient Selection for Treatment of Colorectal Cancer.
Ros J; Baraibar I; Martini G; Salvà F; Saoudi N; Cuadra-Urteaga JL; Dienstmann R; Tabernero J; Élez E
Curr Treat Options Oncol; 2021 Nov; 22(12):113. PubMed ID: 34741675
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive evaluation of coding region point mutations in microsatellite-unstable colorectal cancer.
Kondelin J; Salokas K; Saarinen L; Ovaska K; Rauanheimo H; Plaketti RM; Hamberg J; Liu X; Yadav L; Gylfe AE; Cajuso T; Hänninen UA; Palin K; Ristolainen H; Katainen R; Kaasinen E; Tanskanen T; Aavikko M; Taipale M; Taipale J; Renkonen-Sinisalo L; Lepistö A; Koskensalo S; Böhm J; Mecklin JP; Ongen H; Dermitzakis ET; Kilpivaara O; Vahteristo P; Turunen M; Hautaniemi S; Tuupanen S; Karhu A; Välimäki N; Varjosalo M; Pitkänen E; Aaltonen LA
EMBO Mol Med; 2018 Sep; 10(9):. PubMed ID: 30108113
[TBL] [Abstract][Full Text] [Related]
40. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer.
Loughrey MB; Waring PM; Tan A; Trivett M; Kovalenko S; Beshay V; Young MA; McArthur G; Boussioutas A; Dobrovic A
Fam Cancer; 2007; 6(3):301-10. PubMed ID: 17453358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
